| Name | (2R,3R,4R,5R)-5-[6-(dimethylamino)purin-9-yl]-2-(hydroxymethyl)-4-methoxyoxolan-3-ol |
|---|---|
| Synonyms |
Adenosine, N,N-dimethyl-2'-O-methyl
N6,N6-Dimethyl-2'-O-methyladenosine N6,N6-Dimethyl-2'-O-methyladenosine RNA-modified nucleoside m62Am Adenosine,N,N-dimethyl-2'-O-methyl (2R,3S,5R)-5-(6-(dimethylamino)-9H-purin-9-yl)-2-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol N6,N6-Dimethyl-2’-O-methyladenosine N6,N6,2'-O-Trimethyladenosine N,N-Dimethyl-2'-O-methyladenosine |
| Description | N,N-Dimethyl-2′-O-methyladenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C13H19N5O4 |
|---|---|
| Molecular Weight | 309.32 |
| Exact Mass | 309.14400 |
| PSA | 105.76000 |